CBDL's Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products' Projected 2025 Sales Revenues to Reach $1.8 Million
CBD Life Sciences Inc. (OTC PINK:CBDL) has announced an increased revenue projection for 2025, forecasting $1.8 million in sales for its CBD Vault™ brand. This upward revision is attributed to anticipated organic growth and expected revenue contributions from recently added sales channel partners. The company is also exploring opportunities to establish operating partnerships on a more national scale.
Lisa Nelson, CEO of CBDL, expressed satisfaction with the reception of the CBD Vault™ brand, noting its role in gaining traction and visibility in the competitive CBD products market. The company aims to leverage this increased visibility to secure stronger sales channel partners, which will drive future sales objectives.
CBD Life Sciences Inc. (OTC PINK:CBDL) ha annunciato una previsione di aumento dei ricavi per il 2025, stimando 1,8 milioni di dollari in vendite per il suo marchio CBD Vault™. Questa revisione al rialzo è attribuita a una crescita organica attesa e ai contributi di ricavo provenienti da nuovi partner commerciali. L'azienda sta anche esplorando opportunità per stabilire partnership operative su scala più nazionale.
Lisa Nelson, CEO di CBDL, ha espresso soddisfazione per il ricevimento del marchio CBD Vault™, evidenziando il suo ruolo nel guadagnare attenzione e visibilità nel competitivo mercato dei prodotti CBD. L'azienda mira a sfruttare questa maggiore visibilità per assicurarsi partner commerciali più solidi, il che spingerà gli obiettivi di vendita futuri.
CBD Life Sciences Inc. (OTC PINK:CBDL) ha anunciado una proyección de ingresos aumentados para 2025, pronosticando 1.8 millones de dólares en ventas para su marca CBD Vault™. Esta revisión al alza se atribuye al crecimiento orgánico anticipado y a las contribuciones de ingresos de nuevos socios en el canal de ventas. La empresa también está explorando oportunidades para establecer asociaciones operativas a una escala más nacional.
Lisa Nelson, CEO de CBDL, expresó su satisfacción con la recepción de la marca CBD Vault™, señalando su papel en ganar tracción y visibilidad en el competitivo mercado de productos de CBD. La empresa pretende aprovechar esta mayor visibilidad para asegurar socios comerciales más sólidos, lo que impulsará los objetivos de ventas futuros.
CBD Life Sciences Inc. (OTC PINK:CBDL)는 2025년 매출 전망을 상향 조정하며 180만 달러의 CBD Vault™ 브랜드 매출을 예측했습니다. 이 상향 조정은 예상되는 유기적 성장과 최근 추가된 판매 채널 파트너로부터의 수익 기여에 기인합니다. 회사는 또한 보다 전국적인 차원에서 운영 파트너십 기회를 탐색하고 있습니다.
CBDL의 CEO인 리사 넬슨은 CBD Vault™ 브랜드의 반응에 만족감을 표하며, 경쟁이 치열한 CBD 제품 시장에서의 입지와 가시성을 높이는 데 기여하고 있다고 언급했습니다. 이 회사는 증가된 가시성을 이용해 더 강력한 판매 채널 파트너를 확보하여 향후 매출 목표를 추진할 계획입니다.
CBD Life Sciences Inc. (OTC PINK:CBDL) a annoncé une prévision de revenus augmentée pour 2025, prévoyant 1,8 million de dollars de ventes pour sa marque CBD Vault™. Cette révision à la hausse est attribuée à une croissance organique anticipée et aux contributions de revenus des nouveaux partenaires de canaux de vente récemment ajoutés. L'entreprise explore également des opportunités d'établir des partenariats opérationnels à une échelle plus nationale.
Lisa Nelson, PDG de CBDL, a exprimé sa satisfaction quant à l'accueil de la marque CBD Vault™, soulignant son rôle pour gagner en traction et en visibilité sur le marché concurrentiel des produits CBD. L'entreprise vise à tirer parti de cette visibilité accrue pour sécuriser des partenaires de vente plus solides, ce qui stimulera ses objectifs de vente futurs.
CBD Life Sciences Inc. (OTC PINK:CBDL) hat eine erhöhte Umsatzprognose für 2025 bekannt gegeben und erwartet 1,8 Millionen Dollar an Verkäufen für ihre Marke CBD Vault™. Diese Anpassung nach oben ist auf das erwartete organische Wachstum und die zu erwartenden Umsatzbeiträge von neu hinzugefügten Vertriebspartnern zurückzuführen. Das Unternehmen prüft auch Möglichkeiten, um Betriebskooperationen in größerem Rahmen einzurichten.
Lisa Nelson, CEO von CBDL, äußerte ihre Zufriedenheit über die Aufnahme der Marke CBD Vault™ und hob ihre Rolle bei der Gewinnung von Aufmerksamkeit und Sichtbarkeit im wettbewerbsintensiven CBD-Produkten-Markt hervor. Das Unternehmen plant, diese gesteigerte Sichtbarkeit zu nutzen, um stärkere Vertriebspartner zu gewinnen, die zukünftige Verkaufsziele vorantreiben werden.
- Increased revenue projection for 2025 to $1.8 million
- Recently launched CBD Vault™ brand gaining traction in the market
- Addition of new sales channel partners
- Exploring opportunities for national-scale operating partnerships
- None.
SCOTTSDALE, AZ / ACCESSWIRE / July 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it increased its revenue projection for 2025 to
"As we keep saying, we are extremely pleased with the reception of our CBD VaultTM brand in the way that it has gained us traction towards establishing greater visibility in the highly competitive CBD products market," said Lisa Nelson, CEO of CBDL. "We are committed to leveraging this greater visibility into ever-stronger sales channel partners that, in turn, will drive us to our future sales objectives."
About The CBD Vault Inc. and CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at www.thecbdvault.com
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What is CBD Life Sciences Inc.'s (CBDL) revenue projection for 2025?
What factors are contributing to CBDL's increased revenue projection?
How is CBDL's CBD Vault™ brand performing in the market?